NCT02861651View on ClinicalTrials.gov

Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2015

Conditions
Acute Myeloid Leukemia
Interventions
OTHER

DNA sequencing

Trial Locations (1)

13009

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT02861651 - Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing | Biotech Hunter | Biotech Hunter